Quick Answer
Telix Pharmaceuticals Ltd reported Gross Profit of $426.44 million for fiscal year 2025.
Telix Pharmaceuticals Ltd Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $426.44M | +26.9% |
| 2024 | $336.16M | +60.4% |
| 2023 | $209.53M | +120.7% |
| 2022 | $94.93M | — |
- Telix Pharmaceuticals Ltd showed an increase of +26.9% in Gross Profit compared to the prior fiscal year.
- Over the 2022–2025 period, Telix Pharmaceuticals Ltd’s gross profit has grown by 349.2% (from $94.93 million to $426.44 million).
- The most recent figure is from Telix Pharmaceuticals Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: